Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Clinical Orthopaedics and Related Research|March 17, 2011
Human early fracture hematoma is characterized by inflammation and hypoxiaPaula Kolar, Timo Gaber, Carsten Perka, et al.
Molecular Immunology|April 27, 2010
CTLA-4 (CD152) inhibits T cell function by activating the ubiquitin ligase ItchHolger Hoff, Paula Kolar, Andreas Ambach, et al.
European Journal of Immunology|February 19, 2009
CD152 (CTLA-4) regulates effector functions of CD8+ T lymphocytes by repressing EomesoderminJohannes K Hegel, Karin Knieke, Paula Kolar, et al.
International Orthopaedics|January 18, 2011
Toxicity of antiseptics against chondrocytes: what is best for the cartilage in septic joint surgery?Eric Röhner, Paula Kolar, Joern B Seeger, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|April 22, 2009
Cellular composition of the initial fracture hematoma compared to a muscle hematoma: a study in sheepKatharina Schmidt-Bleek, Hanna Schell, Paula Kolar, et al.
Plos One|May 30, 2009
CD152 (CTLA-4) determines CD4 T cell migration in vitro and in vivoKarin Knieke, Holger Hoff, Frank Maszyna, et al.
Arthritis and Rheumatism|January 1, 2009
CTLA-4 (CD152) controls homeostasis and suppressive capacity of regulatory T cells in micePaula Kolar, Karin Knieke, J Kolja E Hegel, et al.
Tissue Engineering. Part B, Reviews|March 4, 2010
The early fracture hematoma and its potential role in fracture healingPaula Kolar, Katharina Schmidt-Bleek, Hanna Schell, et al.
The Journal of Rheumatology|November 4, 2009
Adaptation of human CD4+ T cells to pathophysiological hypoxia: a transcriptome analysisTimo Gaber, Thomas Häupl, Grit Sandig, et al.
Pageof 1